• Search History (Register)
  • MeSH Browser
  • [Clear]
    • English
    • Afrikaans
      Albanian
      Arabic
      Armenian
      Basque
      Bengali
      Bulgarian
      Catalan
      Cambodian
      Chinese (Mandarin)
      Chinese (Cantonese)
      Croatian
      Czech
      Danish
      Dutch
      English
      Estonian
      Fiji
      Finnish
      French
      Georgian
      German
      Greek
      Gujarati
      Hebrew
      Hindi
      Hungarian
      Icelandic
      Indonesian
      Irish
      Italian
      Japanese
      Javanese
      Korean
      Latin
      Latvian
      Lithuanian
      Macedonian
      Malay
      Malayalam
      Maltese
      Maori
      Marathi
      Mongolian
      Nepali
      Norwegian
      Persian
      Polish
      Portuguese
      Punjabi
      Quechua
      Romanian
      Russian
      Samoan
      Serbian
      Slovak
      Slovenian
      Spanish
      Swahili
      Swedish
      Tamil
      Tatar
      Telugu
      Thai
      Tibetan
      Tonga
      Turkish
      Ukrainian
      Urdu
      Uzbek
      Vietnamese
      Welsh
      Xhosa
      Apply
    • Adelaide Health Technology Assessment
      Agence d'évaluation des technologies et des modes d'intervention en santé
      Agencia de Evaluacion de Tecnologias Sanitarias
      Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS)
      Agencia de Qualitat i Avaluacio Sanitries de Catalunya
      Agency for Care Effectiveness (ACE)
      Agency for Health Technology Assessment and Tariff System
      Agency for Healthcare Research and Quality
      Agenzia Sanitaria e Sociale Regionale (Regional Agency for Health and Social Care)
      All Wales Medicines Strategy Group
      Andalusian Health Technology Assessment Area
      Australian Health Technology Advisory Committee
      Australian Safety and Efficacy Register of New Interventional Procedures-Surgical
      Austrian Institute for Health Technology Assessment
      Basque Office for Health Technology Assessment
      Belgian Health Care Knowledge Centre
      BlueCross BlueShield Association
      British Columbia Office of Health Technology Assessment
      Canadian Agency for Drugs and Technologies in Health
      Canadian Coordinating Office for Health Technology Assessment
      Canadian Task Force on Preventive Health Care
      Canary Health Service
      Cellule Innovation of the AP-HP
      Center for Drug Evaluation
      Center for Medical Technology Assessment
      Center for Outcomes Research and Economic Evaluation for Health
      Centre for Clinical Effectiveness
      Centre for Reviews and Dissemination
      Centre for Technology Assessment at the Swiss Science and Technology Council
      Centre Hospitalier de l'Universite de Montreal
      Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale
      Committee for New Health Technology Assessment
      Conseil d'Evaluation des Technologies de la Santé du Québec
      Coordenação-Geral de Fomento à Pesquisa e Avaliação de Tecnologias em Saúde, Departamento de Ciência e Tecnologia
      Danish Centre for Evaluation and Health Technology Assessment
      Danish Institute for Health Services Research
      ECRI Institute
      European Network for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore
      German Agency for HTA at the German Institute for Medical Documentation and Information
      Gesundheit Osterreich GmbH
      Hannover Medical School, Medizinische Hochschule Hannover
      Haute Autorité de Santé
      HAYES, Inc.
      Health Council of the Netherlands Gezondheidsraad
      Health Information and Quality Authority (HIQA)
      Health Intervention and Technology Assessment Program
      Health Quality Ontario
      Health Sciences Institute in Aragon (IACS)
      Health Services Assessment Collaboration
      Health Services Utilization and Research Commission
      Health Technology Advisory Committee
      Health Technology and Policy Unit
      Health Technology Assessment Section, Ministry of Health Malaysia
      Health Technology Board for Scotland
      Health Technology Reference Group
      Health Technology Wales
      HTA Region Stockholm
      HTA South
      HTA Unit, University of Calgary
      Institut national d'excellence en sante et en services sociaux
      Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval)
      Institute for Clinical and Economic Review
      Institute for Clinical Effectiveness and Health Policy
      Institute for Clinical Evaluative Sciences
      Institute for Clinical Systems Improvement
      Institute for Quality and Efficiency in Health Care (IQWiG)
      Institute of Applied Health Sciences
      Institute of Health Economics
      Institute of Health Economics
      Institute of Health Technology Assessment and Research (IETSI)
      Institute of Technology Assessment
      Israel Center for Technology Assessment in Health Care
      L'Agence Nationale d'Accreditation d'Evaluation en Santé
      Ludwig Boltzmann Institute for Health Technology Assessment
      Malaysian Health Technology Assessment
      Malaysian Health Technology Assessment Unit
      Medical Advisory Secretariat
      Medical Services Advisory Committee
      Monash Business School, Monash University (MBS)
      National Authority for Assessment and Accreditation in Healthcare (INEAS)
      National Committee for Technology Incorporation (CONITEC)
      National Evidence-based healthcare Collaborating Agency
      National Institute for Clinical Excellence
      National Institute for Health and Care Excellence
      New Zealand Health Technology Assessment
      New Zealand National Health Committee
      NIHR Health and Social Care Delivery Program
      NIHR Health Services and Delivery Research programme
      NIHR Health Technology Assessment programme
      NIHR Horizon Scanning Centre
      NIHR Public Health Research programme
      Norwegian Institute of Public Health
      Norwegian Institute of Public Health
      Norwegian Medical Products Agency
      Ontario Health
      Penn Medicine Center for Evidence-based Practice
      Quality Improvement Scotland
      Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)
      Scottish Health Purchasing Information Centre
      Scottish Health Technologies Group
      Scottish Medicines Consortium (SMC)
      State Health Care Accreditation Agency under the Ministry of Health of the Republic of Lithuania
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swiss Federal Office of Public Health (FOPH)
      Technology Assessment at SickKids
      Technology Assessment Unit of the McGill University Health Centre (MUHC)
      The Danish Health Technology Council
      The Federal Joint Committee
      The HTA Center of the Stockholm County Council/Gotland
      The Italian National Agency for Regional Health Services (Agenas)
      The National Health Care Institute (ZIN, Zorginstituut Nederland)
      The National Health Care Institute (Zorginstituut Nederland)
      The Netherlands Organisation for Health Research and Development
      The Regional Health Technology Assessment Centre
      TNO
      U. S. Congress. Office of Technology Assessment
      Unidad de Evaluacion de Tecnologias Sanitarias
      Unidad de Tecnologias de Salud
      Unit of Health Economics and Technology Assessment in Health Care
      University HealthSystem Consortium
      University of York
      VA Technology Assessment Program
      Washington Singer Press
      Washington State Department of Labor and Industries (WSDLI)
      Wessex Institute for Health Research and Development
      West Midlands Health Technology Assessment Collaboration
      WorkSafeBC
      Apply
    • Afghanistan
      Albania
      Algeria
      Andorra
      Antigua and Barbuda
      Argentina
      Armenia
      Australia
      Austria
      Azerbaijan
      Bahamas
      Bahrain
      Bangladesh
      Barbados
      Belarus
      Belgium
      Belize
      Benin
      Bhutan
      Bolivia
      Bosnia and Herzegovina
      Botswana
      Brazil
      Brunei
      Bulgaria
      Burkina Faso
      Burundi
      Cambodia
      Cameroon
      Canada
      Cape Verde
      Central African Republic
      Chad
      Chile
      China
      Colombia
      Comoros
      Congo
      Costa Rica
      Cote dIvoire
      Croatia
      Cuba
      Cyprus
      Czech Republic
      Denmark
      Djibouti
      Dominica
      Dominican Republic
      East Timor
      Ecuador
      Egypt
      El Salvador
      Equatorial Guinea
      Eritrea
      Estonia
      Ethiopia
      Fiji
      Finland
      France
      Gabon
      Gambia
      Georgia
      Germany
      Ghana
      Greece
      Grenada
      Guatemala
      Guinea
      Guinea-Bissau
      Guyana
      Haiti
      Honduras
      Hong Kong
      Hungary
      Iceland
      India
      Indonesia
      Iran
      Iraq
      Ireland
      Israel
      Italy
      Jamaica
      Japan
      Jordan
      Kazakhstan
      Kenya
      Kiribati
      North Korea
      South Korea
      Kuwait
      Kyrgyzstan
      Laos
      Latvia
      Lebanon
      Lesotho
      Liberia
      Libya
      Liechtenstein
      Lithuania
      Luxembourg
      Macedonia
      Madagascar
      Malawi
      Malaysia
      Maldives
      Mali
      Malta
      Marshall Islands
      Mauritania
      Mauritius
      Mexico
      Micronesia
      Moldova
      Monaco
      Mongolia
      Montenegro
      Morocco
      Mozambique
      Myanmar
      Namibia
      Nauru
      Nepal
      Netherlands
      New Zealand
      Nicaragua
      Niger
      Nigeria
      Norway
      Oman
      Pakistan
      Palau
      Panama
      Papua New Guinea
      Paraguay
      Peru
      Philippines
      Poland
      Portugal
      Puerto Rico
      Qatar
      Romania
      Russia
      Rwanda
      Saint Kitts and Nevis
      Saint Lucia
      Saint Vincent and the Grenadines
      Samoa
      San Marino
      Sao Tome and Principe
      Saudi Arabia
      Senegal
      Serbia and Montenegro
      Seychelles
      Sierra Leone
      Singapore
      Slovakia
      Slovenia
      Solomon Islands
      Somalia
      South Africa
      Spain
      Sri Lanka
      Sudan
      Suriname
      Swaziland
      Sweden
      Switzerland
      Syria
      Taiwan
      Tajikistan
      Tanzania
      Thailand
      Togo
      Tonga
      Trinidad and Tobago
      Tunisia
      Turkey
      Turkmenistan
      Tuvalu
      Uganda
      Ukraine
      United Arab Emirates
      United Kingdom
      United States
      Uruguay
      Uzbekistan
      Vanuatu
      Vatican City
      Venezuela
      Vietnam
      Yemen
      Zambia
      Zimbabwe
      Apply

Welcome to the international HTA database

CSV RIS
Showing [16495 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2013     Health Quality Ontario (HQO) Optimal timing of hip fracture surgery: a rapid review
2013     NIHR Health Technology Assessment programme The Percutaneous shunting in Lower Urinary Tract Obstruction (PLUTO) study and randomised controlled trial: evaluation of the effectiveness, cost-effectiveness and acceptability of percutaneous vesicoamniotic shunting for lower urinary tract obstruction
2013     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Vildagliptin (Galvus®) 50 mg tablets
2013     NIHR Horizon Scanning Centre (NIHR HSC) Elotuzumab for relapsed or refractory multiple myeloma
2013     Health Quality Ontario (HQO) Intramedullary nails in comparison with sliding hip screws for intertrochanteric hip fractures: a rapid review
2013     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Racecadotril (Hidrasec®) 10 mg and 30 mg granules for oral suspension
2013     NIHR Horizon Scanning Centre (NIHR HSC) Gefitinib (Iressa) with chemotherapy for EGFR-positive non-small cell lung cancer – second line
2013     Health Quality Ontario (HQO) Intensity of rehabilitation after hip fracture: a rapid review
2013     Health Information and Quality Authority (HIQA) A series of health technology assessments (HTAs) of clinical referral or treatment thresholds for scheduled surgical procedures. Phase I
2013     NIHR Health Technology Assessment programme A systematic review and economic evaluation of subcutaneous and sublingual allergen immunotherapy in adults and children with seasonal allergic rhinitis
2013     NIHR Horizon Scanning Centre (NIHR HSC) Ibrutinib for relapsed or refractory chronic lymphocytic leukaemia – second line
2013     Health Quality Ontario (HQO) Community versus inpatient rehabilitation in hip fracture patients: a rapid review
2013     Adelaide Health Technology Assessment (AHTA) Genetic testing for hereditary mutations in the RET gene
2013     Health Information and Quality Authority (HIQA) A series of health technology assessments (HTAs) of clinical referral or treatment thresholds for scheduled surgical procedures. Phase II
2013     NIHR Horizon Scanning Centre (NIHR HSC) Idelalisib with rituximab for chronic lymphocytic leukaemia
2013     Health Quality Ontario (HQO) Clinical utility of echocardiography for patients with hip fracture: a rapid review
2013     NIHR Health Technology Assessment programme The impact of continuous haemofiltration with high-volume fluid exchange during cardiopulmonary bypass surgery on the recovery of patients with impaired renal function: a pilot randomised trial
2013     NIHR Horizon Scanning Centre (NIHR HSC) Idelalisib for indolent non-Hodgkin's lymphoma
2013     Health Quality Ontario (HQO) Total hip arthroplasty versus hemiarthroplasty for displaced femoral neck fractures: a rapid review
2013     NIHR Horizon Scanning Centre (NIHR HSC) Abraxane in combination with gemcitabine for metastatic pancreatic cancer – first line
2013     NIHR Horizon Scanning Centre (NIHR HSC) Lambrolizumab for advanced melanoma – second line; refractory to ipilimumab
2013     Health Quality Ontario (HQO) Periodic health examinations: a rapid economic analysis
2013     NIHR Horizon Scanning Centre (NIHR HSC) Bevacizumab (Avastin) for relapsed platinum-resistant ovarian cancer – second line
2013     NIHR Horizon Scanning Centre (NIHR HSC) Onartuzumab for metastatic Met positive non-small cell lung cancer
2013     Health Quality Ontario (HQO) Antibiotic coverage in atypical pathogens for adults hospitalized with community-acquired pneumonia: a rapid review
2013     NIHR Horizon Scanning Centre (NIHR HSC) Apixaban (Eliquis) for the treatment and prevention of venous thromboembolic events
2013     Institute of Health Economics (IHE) Stingray catheter and guidewire for recanalization of coronary chronic total occlusions: a rapid evidence assessment
2013     Health Quality Ontario (HQO) Monotherapy versus combination therapy for adults hospitalized for community-acquired pneumonia: a rapid review
2013     NIHR Horizon Scanning Centre (NIHR HSC) Erismodegib for locally advanced or metastatic basal cell carcinoma
2013     NIHR Horizon Scanning Centre (NIHR HSC) LCZ696 for chronic heart failure – first line
2013     Institute of Health Economics (IHE) Transcutaneous bilirubinometry for the screening of neonatal hyperbilirubinemia ≥35 weeks' gestation
2013     Health Quality Ontario (HQO) Optimal timing for antibiotic administration in patients with community-acquired pneumonia: a rapid review
2013     NIHR Horizon Scanning Centre (NIHR HSC) Erlotinib (Tarceva) for the adjuvant treatment of EGFR positive non-small cell lung cancer
2013     NIHR Horizon Scanning Centre (NIHR HSC) Ticagrelor (Brilique) for secondary prevention of cardiovascular disease events in patients with prior myocardial infarction
2013     Health Information and Quality Authority (HIQA) Health technology assessment (HTA) of intermittent pneumatic compression for severe peripheral arterial disease
2013     Health Quality Ontario (HQO) Severity assessment tools for patients with community-acquired pneumonia: a rapid review
2013     NIHR Horizon Scanning Centre (NIHR HSC) LCQ908 (Pradigastat) for familial chylomicronaemia syndrome – first line
2013     Health Quality Ontario (HQO) Usefulness of urinary antigen testing for Legionella in the treatment of community-acquired pneumonia: a rapid review
2013     NIHR Horizon Scanning Centre (NIHR HSC) Gevokizumab for chronic non-infectious uveitis
2013     NIHR Horizon Scanning Centre (NIHR HSC) Alicaforsen for pouchitis – second line
2013     Health Quality Ontario (HQO) Shorter versus longer duration of antibiotic therapy in patients with community-acquired pneumonia: a rapid review
2013     NIHR Horizon Scanning Centre (NIHR HSC) ABT-450/ritonavir/ABT-267 in combination with ABT-333 for chronic genotype-1 hepatitis C infection
2013     NIHR Horizon Scanning Centre (NIHR HSC) Trastuzumab emtansine (Kadcyla) for patients with HER2 positive locally advanced or metastatic relapsed gastric cancers
2013     Health Quality Ontario (HQO) Role of screening for respiratory syncytial virus or influenza and empirical antiviral treatment for patients with community-acquired pneumonia: a rapid review
2013     NIHR Horizon Scanning Centre (NIHR HSC) Sofosbuvir with ledipasvir for hepatitis C, genotype 1
2013     NIHR Horizon Scanning Centre (NIHR HSC) Ramucirumab for hepatocellular cancer – second line
2013     Health Quality Ontario (HQO) Criteria for switching from intravenous to oral antibiotics in patients hospitalized with community-acquired pneumonia: a rapid review
2013     NIHR Horizon Scanning Centre (NIHR HSC) Leuco-methylthioninium for alzheimer's disease
2013     NIHR Horizon Scanning Centre (NIHR HSC) Pixantrone (Pixuvri) in combination with rituximab for diffuse large B-cell lymphoma or grade 3 follicular lymphoma – second and subsequent line
2013     Health Quality Ontario (HQO) Local infiltration analgesia in hip and knee arthroplasty: a rapid review
2013     NIHR Horizon Scanning Centre (NIHR HSC) Miniprobes™ for probe-based confocal laser endomicroscopy in bladder, pancreatic or bile duct cancer
2013     NIHR Health Technology Assessment programme Degarelix for treating advanced hormone-dependent prostate cancer
2013     NIHR Horizon Scanning Centre (NIHR HSC) Ofatumumab (Arzerra) for relapsed chronic lymphocytic leukaemia
2013     Health Quality Ontario (HQO) Anesthesia among patients undergoing knee arthroplasty: a rapid review
2013     NIHR Horizon Scanning Centre (NIHR HSC) Glysure intravascular continuous glucose monitoring system for glycaemic control in intensive care
2013     NIHR Horizon Scanning Centre (NIHR HSC) IceSense3™ Cryoablation System for breast fibroadenoma
2013     NIHR Horizon Scanning Centre (NIHR HSC) MEK162 for NRAS mutation positive advanced malignant melanoma – first and second line
2013     Health Quality Ontario (HQO) Intensity of rehabilitation during the acute hospitalization period after hip or knee arthroplasty: a rapid review
2013     NIHR Horizon Scanning Centre (NIHR HSC) Afatinib for locally advanced, recurrent or metastatic head and neck squamous cell carcinoma – second line
2013     NIHR Horizon Scanning Centre (NIHR HSC) EndoVE® for colorectal cancer
2013     NIHR Horizon Scanning Centre (NIHR HSC) MK-3475 for advanced melanoma – first or second line, in patients naïve to ipilimumab
2013     Health Quality Ontario (HQO) Simultaneous or staged bilateral knee arthroplasty: a rapid review
2013     NIHR Health Services and Delivery Research programme A Mortality Risk Model to Adjust for Case Mix in UK Paediatric Cardiac Surgery
2013     NIHR Horizon Scanning Centre (NIHR HSC) Astuprotimut-r (Zumagev) for stage III, MAGE-A3 positive malignant melanoma – adjuvant therapy
2013     NIHR Horizon Scanning Centre (NIHR HSC) Curodont™ Repair and Curodont Protect™ for the treatment and prevention of tooth decay
2013     NIHR Health Technology Assessment programme Alemtuzumab for the treatment of relapsing-remitting multiple sclerosis
2013     NIHR Horizon Scanning Centre (NIHR HSC) MK-3475 for advanced or recurrent PD-L1 positive non-small cell lung cancer – second line
2013     Health Quality Ontario (HQO) Antibiotic-laden bone cement for primary knee arthroplasty: a rapid review
2013     NIHR Health Services and Delivery Research programme Exploring types of individual unlearning by local health-care managers: an original empirical approach
2013     NIHR Horizon Scanning Centre (NIHR HSC) Lapatinib (Tyverb) for HER2-positive breast cancer – adjuvant therapy in combination with or following trastuzumab
2013     NIHR Horizon Scanning Centre (NIHR HSC) ARGOS-IO for the measurement of intraocular pressure in glaucoma
2013     NIHR Health Technology Assessment programme Ustekinumab for treating active and progressive psoriatic arthritis
2013     NIHR Horizon Scanning Centre (NIHR HSC) Bevacizumab (Avastin) for newly diagnosed glioblastoma multiforme – first line
2013     Health Quality Ontario (HQO) The effectiveness of cement in primary hip replacements: a rapid review
2013     NIHR Health Services and Delivery Research programme Support matters: a mixed methods scoping study on the use of assistant staff in the delivery of community nursing services in England
2013     NIHR Horizon Scanning Centre (NIHR HSC) Trebananib in combination with chemotherapy for recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer
2013     NIHR Horizon Scanning Centre (NIHR HSC) LDK378 for ALK-activated advanced non-small cell lung cancer – second and subsequent lines
2013     NIHR Horizon Scanning Centre (NIHR HSC) EndoStim LES Stimulation System for severe gastro-oesophageal reflux
2013     NIHR Health Technology Assessment programme Bosutinib for previously treated chronic myeloid leukaemia: a single technology appraisal
2013     NIHR Horizon Scanning Centre (NIHR HSC) Asfotase alfa for hypophosphatasia
2013     NIHR Health Services and Delivery Research programme How do they manage? A qualitative study of the realities of middle and front-line management work in health care
2013     NIHR Horizon Scanning Centre (NIHR HSC) Tertomotide for locally advanced or metastatic pancreatic cancer
2013     NIHR Horizon Scanning Centre (NIHR HSC) Ofatumumab (Arzerra) for relapsed diffuse large B-cell lymphoma
2013     NIHR Horizon Scanning Centre (NIHR HSC) IUB™ SCu300A intrauterine device for contraception
2013     NIHR Health Technology Assessment programme Teriflunomide for treating relapsing forms of multiple sclerosis
2013     NIHR Horizon Scanning Centre (NIHR HSC) Methyl aminolevulinate (Visonac) photodynamic therapy for acne vulgaris
2013     NIHR Health Services and Delivery Research programme Health and social care services for older male adults in prison: the identification of current service provision and piloting of an assessment and care planning model
2013     NIHR Horizon Scanning Centre (NIHR HSC) Ospemifene for vulvo-vaginal atrophy in postmenopausal women
2013     NIHR Horizon Scanning Centre (NIHR HSC) Orteronel for metastatic hormone-relapsed prostate cancer following chemotherapy
2013     NIHR Horizon Scanning Centre (NIHR HSC) HiberGene Meningococcal LAMP assay for rapid detection of meningitis and/or septicaemia
2013     NIHR Health Technology Assessment programme Dimethyl fumarate for treating relapsing-remitting multiple sclerosis
2013     NIHR Horizon Scanning Centre (NIHR HSC) Dimethyl fumarate for plaque psoriasis
2013     NIHR Health Services and Delivery Research programme Towards a framework for enhancing the performance of NHS boards: a synthesis of the evidence about board governance, board effectiveness and board development
2013     NIHR Horizon Scanning Centre (NIHR HSC) Avatrombopag for immune (idiopathic) thrombocytopenic purpura
2013     NIHR Horizon Scanning Centre (NIHR HSC) TK cell therapy for acute leukaemia patients who are candidate to haematopoietic stem cell transplantation – adjunct therapy
2013     NIHR Horizon Scanning Centre (NIHR HSC) ProUroScan™ for imaging abnormalities of the prostate
2013     NIHR Horizon Scanning Centre (NIHR HSC) Apremilast for ankylosing spondylitis
2013     NIHR Health Services and Delivery Research programme Facilitating knowledge exchange between health-care sectors, organisations and professions: a longitudinal mixed-methods study of boundary-spanning processes and their impact on health-care quality
2013     NIHR Horizon Scanning Centre (NIHR HSC) Preladenant for Parkinson's disease – monotherapy or adjunct to levodopa therapy
2013     NIHR Horizon Scanning Centre (NIHR HSC) Volasertib for acute myeloid leukaemia in patients ineligible for intensive induction therapy – first line